News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,582 Results
Type
Article (88443)
Company Profile (813)
Press Release (788296)
Multimedia
Podcasts (222)
Webinars (34)
Section
Business (233443)
Career Advice (4155)
Deals (39928)
Drug Delivery (170)
Drug Development (91565)
Employer Resources (207)
FDA (18491)
Job Trends (17461)
News (398384)
Policy (40010)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (178)
Alliances (56985)
ALS (211)
Alzheimer's disease (1900)
Antibody-drug conjugate (ADC) (447)
Approvals (18744)
Artificial intelligence (762)
Autoimmune disease (264)
Automation (56)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (226)
Biotechnology (486)
Bladder cancer (189)
Brain cancer (76)
Breast cancer (741)
Cancer (5826)
Cardiovascular disease (514)
Career advice (3585)
Career pathing (48)
CAR-T (337)
CDC (73)
Celiac Disease (2)
Cell therapy (931)
Cervical cancer (45)
Clinical research (78026)
Collaboration (2173)
Company closure (7)
Compensation (1349)
Complete response letters (96)
COVID-19 (3019)
CRISPR (112)
C-suite (1107)
Cystic fibrosis (161)
Data (7445)
Decentralized trials (3)
Denatured (83)
Depression (179)
Dermatology (72)
Diabetes (601)
Diagnostics (7448)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (382)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (101417)
Editorial (73)
Employer branding (25)
Employer resources (174)
Events (136773)
Executive appointments (1129)
FDA (22169)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1784)
Gene editing (242)
Generative AI (85)
Gene therapy (764)
GLP-1 (1221)
Government (5522)
Grass and pollen (8)
Guidances (404)
Healthcare (21058)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (164)
Infectious disease (3383)
Inflammatory bowel disease (225)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (288)
Interviews (817)
IPO (17979)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (20)
Labor market (107)
Layoffs (672)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (31)
Lung cancer (777)
Lymphoma (422)
Machine learning (57)
Management (66)
Manufacturing (1061)
MASH (196)
Medical device (15176)
Medtech (15264)
Mergers & acquisitions (23149)
Metabolic disorders (1621)
mRNA (222)
Multiple sclerosis (188)
NASH (24)
Neurodegenerative disease (442)
Neuropsychiatric disorders (117)
Neuroscience (3467)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (793)
Opinion (360)
Ovarian cancer (202)
Pain (258)
Pancreatic cancer (280)
Parkinson's disease (376)
Partnered (39)
Patents (596)
Patient recruitment (649)
Peanut (65)
People (67538)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24100)
Phase 2 (33875)
Phase 3 (25489)
Pipeline (7685)
Policy (378)
Postmarket research (3556)
Preclinical (10819)
Press Release (72)
Prostate cancer (298)
Psychedelics (61)
Radiopharmaceuticals (341)
Rare diseases (1131)
Real estate (7449)
Recruiting (81)
Regulatory (29798)
Reports (75)
Research institute (2759)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (24)
RSV (98)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (30)
Sickle cell disease (115)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4351)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1241)
Venture capital (113)
Weight loss (545)
Women's health (121)
Worklife (24)
Date
Today (40)
Last 7 days (663)
Last 30 days (2739)
Last 365 days (32932)
2026 (9913)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (375)
Arkansas (16)
Asia (51939)
Australia (9131)
California (13022)
Canada (3700)
China (1369)
Colorado (564)
Connecticut (578)
Delaware (395)
Europe (119622)
Florida (1944)
Georgia (427)
Hawaii (4)
Idaho (69)
Illinois (1120)
India (93)
Indiana (615)
Iowa (24)
Japan (524)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1603)
Massachusetts (9538)
Michigan (396)
Minnesota (738)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (91)
New Jersey (3503)
New Mexico (33)
New York (3452)
North Carolina (1773)
North Dakota (10)
Northern California (6360)
Ohio (404)
Oklahoma (26)
Oregon (55)
Pennsylvania (2606)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (84)
South Dakota (2)
Southern California (5083)
Tennessee (208)
Texas (2104)
United States (46904)
Utah (394)
Vermont (1)
Virginia (331)
Washington D.C. (88)
Washington State (1080)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 877,582 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marvel Biosciences Announces Closing of Convertible Debenture Offering
April 17, 2026
·
4 min read
Press Releases
Virtual Discovery Announces Strategic Partnership with SPR CRO to Accelerate Hit Validation and Lead Optimization
Integrated in silico and experimental workflow enables early-stage teams to move from target to validated leads with greater speed and confidence.
April 17, 2026
·
1 min read
Layoff Tracker
Astellas’ consolidation efforts to impact 50 Universal Cells employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
April 17, 2026
·
48 min read
·
BioSpace Editorial Staff
Press Releases
Model Medicines to Present at ESCMID Global 2026: MDL-001, a Universal Direct-Acting Antiviral for Influenza-Like Illness and Chronic Hepatitis
Two oral presentations highlight first-in-class Thumb-1 polymerase inhibitor with single-agent broad-spectrum efficacy against influenza, RSV, SARS-CoV-2, HCV, HBV and HDV
April 17, 2026
·
1 min read
Press Releases
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
April 17, 2026
·
4 min read
GLP-1
Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch
While Novo Nordisk’s Wegovy pill reached more than 3,000 patients in its first week on the market, analysts at RBC Capital Markets said a direct comparison of the two figures could be misleading given the shorter data collection time for Foundayo.
April 17, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 17, 2026
April 17, 2026
·
1 min read
Press Releases
Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
April 17, 2026
·
8 min read
Press Releases
Volastra Therapeutics Announces Biomarker and Combination Data around AACR 2026 Defining an Rb Pathway-Driven Pan-Cancer Development Strategy for KIF18A Inhibitors
April 17, 2026
·
4 min read
Press Releases
European Commission Approves Merck’s ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants During Their First RSV Season
April 17, 2026
·
11 min read
1 of 87,759
Next
